Donald M. Lyall, Andrey Kormilitzin, Claire Lancaster, Jose Sousa, Fanny Petermann-Rocha, Christopher Buckley, Eric L. Harshfield, Matthew H. Iveson, Christopher R. Madan, Ríona McArdle, Danielle Newby, Vasiliki Orgeta, Eugene Tang, Stefano Tamburin, Lokendra S. Thakur, Ilianna Lourida, The Deep Dementia Phenotyping (DEMON) Network, David J. Llewellyn, Janice M. Ranson

The use of applied modeling in dementia risk prediction, diagnosis, and prognostics will have substantial public health benefits, particularly as “deep phenotyping” cohorts with multi-omics health data become available.